dr. subhayan sur
Dr. D. Y. Patil Biotechnology & Bioinformatics Institute
Pune, India
Review Editor
Cancer Molecular Targets and Therapeutics
Dr. D. Y. Patil Biotechnology & Bioinformatics Institute
Pune, India
Review Editor
Cancer Molecular Targets and Therapeutics
The Scripps Research Institute
La Jolla, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Warren Alpert Medical School, Brown University
Providence, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Juntendo University
BunkyĹŤ, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
Catholic University of the Sacred Heart, Rome
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Health Sciences University of Hokkaido
Tobetsu, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
Shanghai East Hospital, School of Medicine, Tongji University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
Institute of Oncology Research (IOR)
Bellinzona, Switzerland
Review Editor
Cancer Molecular Targets and Therapeutics
Federal University of Ceara
Fortaleza, Brazil
Review Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute (NIH)
Rockville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Syneos Health (United States)
Morrisville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute (NIH)
Rockville, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Orthopedics, Henan Provincial Cancer Hospital
Zhengzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
University of Ferrara
Ferrara, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Xuzhou Medical University
Xuzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics